Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12113) 12113
Newspaper Article (1395) 1395
Book Chapter (128) 128
Magazine Article (103) 103
Web Resource (89) 89
Newsletter (23) 23
Book / eBook (12) 12
Trade Publication Article (10) 10
Publication (9) 9
Dissertation (7) 7
Conference Proceeding (6) 6
Paper (3) 3
Book Review (2) 2
Government Document (2) 2
Reference (2) 2
Journal / eJournal (1) 1
Streaming Video (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9354) 9354
science & technology (7321) 7321
life sciences & biomedicine (7112) 7112
vomiting (6172) 6172
female (6127) 6127
male (4781) 4781
nausea (4226) 4226
adult (4102) 4102
middle aged (3708) 3708
vomiting - prevention & control (3705) 3705
antiemetics - therapeutic use (3000) 3000
vomiting - chemically induced (2814) 2814
biological and medical sciences (2750) 2750
medical sciences (2683) 2683
aged (2455) 2455
nausea - prevention & control (2386) 2386
nausea - chemically induced (2003) 2003
anesthesiology (2002) 2002
chemotherapy (1971) 1971
postoperative nausea and vomiting - prevention & control (1922) 1922
double-blind method (1855) 1855
oncology (1762) 1762
adolescent (1635) 1635
antineoplastic agents - adverse effects (1564) 1564
pharmacology. drug treatments (1545) 1545
abridged index medicus (1530) 1530
child (1444) 1444
treatment outcome (1413) 1413
prospective studies (1336) 1336
surgery (1311) 1311
antiemetics - administration & dosage (1242) 1242
anesthesia (1226) 1226
patients (1214) 1214
pain (1170) 1170
cancer (1162) 1162
risk factors (1145) 1145
diarrhea (1042) 1042
child, preschool (1040) 1040
vomiting - etiology (1029) 1029
pediatrics (1002) 1002
prevention (918) 918
care and treatment (878) 878
drug therapy, combination (858) 858
ondansetron - therapeutic use (853) 853
neoplasms - drug therapy (840) 840
clinical trials (820) 820
vomiting - drug therapy (820) 820
nursing (816) 816
medicine & public health (805) 805
antiemetics (792) 792
postoperative nausea and vomiting (792) 792
pharmacology & pharmacy (781) 781
research (765) 765
animals (760) 760
general & internal medicine (755) 755
health aspects (750) 750
analysis (708) 708
dexamethasone (702) 702
ondansetron (699) 699
time factors (694) 694
young adult (694) 694
antiemetics - adverse effects (683) 683
pain, postoperative - prevention & control (680) 680
cisplatin - adverse effects (675) 675
dexamethasone - therapeutic use (675) 675
nausea - drug therapy (667) 667
infant (659) 659
postoperative complications - prevention & control (659) 659
digestive system (657) 657
pregnancy (649) 649
medicine, general & internal (647) 647
aged, 80 and over (637) 637
drug dosages (609) 609
medicine (600) 600
anesthesia. intensive care medicine. transfusions. cell therapy and gene therapy (580) 580
incidence (576) 576
children (575) 575
drug therapy (574) 574
nausea - etiology (556) 556
studies (556) 556
antineoplastic combined chemotherapy protocols - adverse effects (536) 536
infections (530) 530
retrospective studies (530) 530
medical research (514) 514
dose-response relationship, drug (511) 511
postoperative nausea and vomiting - epidemiology (500) 500
fever (488) 488
serotonin antagonists - therapeutic use (488) 488
cancer therapies (484) 484
metoclopramide - therapeutic use (484) 484
complications and side effects (474) 474
health care sciences & services (474) 474
dexamethasone - administration & dosage (473) 473
quality of life (469) 469
hospitals (465) 465
research article (461) 461
drug toxicity and drugs side effects treatment (447) 447
drug administration schedule (446) 446
pain medicine (442) 442
ondansetron - administration & dosage (432) 432
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13059) 13059
German (254) 254
Japanese (252) 252
French (170) 170
Spanish (92) 92
Chinese (77) 77
Italian (73) 73
Russian (67) 67
Portuguese (41) 41
Polish (27) 27
Danish (23) 23
Turkish (22) 22
Korean (15) 15
Hungarian (13) 13
Norwegian (9) 9
Swedish (9) 9
Dutch (7) 7
Serbian (6) 6
Czech (5) 5
Hebrew (4) 4
Persian (4) 4
Romanian (4) 4
Ukrainian (4) 4
Croatian (3) 3
Bulgarian (2) 2
Finnish (2) 2
Icelandic (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting
by Navari, Rudolph M and Qin, Rui and Ruddy, Kathryn J and Liu, Heshan and Powell, Steven F and Bajaj, Madhuri and Dietrich, Leah and Biggs, David and Lafky, Jacqueline M and Loprinzi, Charles L
The New England journal of medicine, ISSN 0028-4793, 07/2016, Volume 375, Issue 2, pp. 134 - 142
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Aprepitant | Olanzapine | Double-Blind Method | Nausea - chemically induced | Humans | Middle Aged | Male | Nausea - prevention & control | Vomiting - chemically induced | Dexamethasone - therapeutic use | Antineoplastic Agents - adverse effects | Antiemetics - therapeutic use | Intention to Treat Analysis | Aged, 80 and over | Adult | Antiemetics - adverse effects | Female | Aged | Benzodiazepines - adverse effects | Drug Therapy, Combination | Benzodiazepines - therapeutic use | Vomiting - prevention & control | Morpholines - therapeutic use | Complications and side effects | Care and treatment | Chemotherapy | Vomiting | Dosage and administration | Nausea | Cancer | Heart attacks | Dexamethasone | Serotonin | Nervous system | Doxorubicin | Cisplatin | Studies | Psychotropic drugs | Cyclophosphamide | Diabetes | Drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Dihydroartemisinin–Piperaquine for the Prevention of Malaria in Pregnancy
by Kakuru, Abel and Jagannathan, Prasanna and Muhindo, Mary K and Natureeba, Paul and Awori, Patricia and Nakalembe, Miriam and Opira, Bishop and Olwoch, Peter and Ategeka, John and Nayebare, Patience and Clark, Tamara D and Feeney, Margaret E and Charlebois, Edwin D and Rizzuto, Gabrielle and Muehlenbachs, Atis and Havlir, Diane V and Kamya, Moses R and Dorsey, Grant
The New England journal of medicine, ISSN 0028-4793, 03/2016, Volume 374, Issue 10, pp. 928 - 939
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Humans | Sulfadoxine - adverse effects | Quinolines - administration & dosage | Incidence | Young Adult | Malaria - epidemiology | Sulfadoxine - therapeutic use | Adult | Female | Parasitemia - epidemiology | Drug Resistance | Pyrimethamine - therapeutic use | Antimalarials - adverse effects | Double-Blind Method | Drug Administration Schedule | Pyrimethamine - adverse effects | Artemisinins - administration & dosage | Antimalarials - therapeutic use | Malaria - prevention & control | Pregnancy | Vomiting - chemically induced | Adolescent | Pregnancy Complications, Parasitic - prevention & control | Uganda | Artemisinins - adverse effects | Drug Combinations | Pregnancy Outcome | Quinolines - adverse effects | Care and treatment | Usage | Malaria | Pregnant women | Pyrimethamine | Clinical trials | Dosage and administration | Health aspects | Dihydroartemisinin | Preventive medicine | Studies | Placenta | Womens health | Vomiting | Human immunodeficiency virus--HIV | Sulfadoxine | Parasitemia | Drug therapy | Adolescents | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Single-Dose Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated With Cisplatin Therapy: Randomized, Double-Blind Study Protocol—EASE
by Steven Grunberg and Daniel Chua and Anish Maru and José Dinis and Suzanne DeVandry and Judith A. Boice and James S. Hardwick and Elizabeth Beckford and Arlene Taylor and Alexandra Carides and Fausto Roila and Jørn Herrstedt
Journal of clinical oncology, ISSN 0732-183X, 04/2011, Volume 29, Issue 11, pp. 1495 - 1501
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Tumors | Dexamethasone - administration & dosage | Double-Blind Method | Drug Administration Schedule | Nausea - chemically induced | Humans | Middle Aged | Morpholines - administration & dosage | Antiemetics - administration & dosage | Ondansetron - administration & dosage | Male | Treatment Outcome | Nausea - prevention & control | Vomiting - chemically induced | Dexamethasone - therapeutic use | Antineoplastic Agents - adverse effects | Ondansetron - therapeutic use | Antiemetics - therapeutic use | Aged, 80 and over | Cisplatin - adverse effects | Adult | Female | Aged | Vomiting - prevention & control | Morpholines - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Postpartum Hemorrhage: Prevention and Treatment
by Evensen, Ann, MD and Anderson, Janice M., MD and Fontaine, Patricia, MD, MS
American family physician, ISSN 0002-838X, 2017, Volume 95, Issue 7, pp. 442 - 449B
Internal Medicine | Medicine, General & Internal | Primary Health Care | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Pregnancy | Oxytocin - administration & dosage | Guidelines as Topic | Postpartum Hemorrhage - prevention & control | Postpartum Hemorrhage - therapy | Postpartum Hemorrhage - diagnosis | Humans | Oxytocics - administration & dosage | Female | Treatment Outcome | Postpartum Hemorrhage - etiology | Blood Transfusion - methods | Prevention | Treatment outcome | Care and treatment | Oxytocin | Analysis | Dosage and administration | Diagnosis | Health aspects | Uterine bleeding | Childbirth | Episiotomy | Postpartum period | Physicians | Anemia | Fetuses | Nausea | FDA approval | Blood banks | Hemorrhage | Obstetrics | Risk factors | Hypotension | Childbirth & labor | Disease prevention | Maternal mortality | Placenta | Uterus | Ischemia | Womens health | Vomiting | Hemoglobin | Patient safety | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Monoclonal antibodies for migraine prevention progress, but not a panacea
by Loder, Elizabeth W and Robbins, Matthew S
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 05/2018, Volume 319, Issue 19, pp. 1985 - 1987
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Calcitonin Gene-Related Peptide | Migraine Disorders | Antibodies, Monoclonal | Disease prevention | Prevention | Headache | Vomiting | Migraine | Neurological complications | Monoclonal antibodies | Nausea
Journal Article
Details down arrow
6. Full Text Duration of dexamethasone administration for the prevention of chemotherapy-induced nausea and vomiting – A systematic review and meta-analysis
by Raghunath, Ajay and Chandrasekara, Sahan D and Anthony, Shane N and Markman, Ben
Critical reviews in oncology/hematology, ISSN 1040-8428, 08/2020, Volume 152, pp. 103012 - 103012
NK1 inhibitors | Systematic review | Dexamethasone | Corticosteroids | Chemotherapy-induced nausea and vomiting | Meta-analysis | Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Prevention | Complications and side effects | Medical research | Chemotherapy | Analysis | Medicine, Experimental | Nausea | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Prevention of chemotherapy-induced nausea: the role of neurokinin-1 (NK1) receptor antagonists
by Bošnjak, Snežana M and Gralla, Richard J and Schwartzberg, Lee
Supportive care in cancer, ISSN 0941-4355, 5/2017, Volume 25, Issue 5, pp. 1661 - 1671
Chemotherapy-induced nausea and vomiting (CINV) | Pain Medicine | Nursing | Rehabilitation Medicine | Medicine & Public Health | Nursing Research | NK 1 receptor antagonist | Chemotherapy-induced nausea (CIN) | Oncology | Antiemetic guidelines | receptor antagonist | Health Care Sciences & Services | Rehabilitation | Life Sciences & Biomedicine | Science & Technology | Vomiting - chemically induced | Nausea - chemically induced | Antineoplastic Agents - adverse effects | Antiemetics - therapeutic use | Humans | Neurokinin-1 Receptor Antagonists - therapeutic use | Quality of Life - psychology | Prevention | Medical colleges | Chemotherapy | Dexamethasone | Nausea | Patient compliance | Cancer | Side effects | Antagonist drugs | Clinical outcomes | Meta-analysis | Index Medicus | Review | NK1 receptor antagonist
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease
by Ataga, Kenneth I and Kutlar, Abdullah and Kanter, Julie and Liles, Darla and Cancado, Rodolfo and Friedrisch, João and Guthrie, Troy H and Knight-Madden, Jennifer and Alvarez, Ofelia A and Gordeuk, Victor R and Gualandro, Sandra and Colella, Marina P and Smith, Wally R and Rollins, Scott A and Stocker, Jonathan W and Rother, Russell P
The New England journal of medicine, ISSN 0028-4793, 02/2017, Volume 376, Issue 5, pp. 429 - 439
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | P-Selectin - antagonists & inhibitors | Double-Blind Method | Pain - prevention & control | Anemia, Sickle Cell - complications | Antibodies, Monoclonal - pharmacology | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Anemia, Sickle Cell - drug therapy | Young Adult | Adolescent | Pain - etiology | Quality of Life | Adult | Female | Hydroxyurea - therapeutic use | Drug Therapy, Combination | P-Selectin - immunology | Viral antibodies | Prevention | Usage | Care and treatment | Safety and security measures | Sickle cell anemia | Antibodies | Dosage and administration | Patients | Occlusion | Spleen | Chest | Arthralgia | Body weight | Neutrophils | Diarrhea | Hydroxyurea | Inflammation | Pruritus | Cell interactions | Endothelial cells | Endothelium | Pain | Blood platelets | Vomiting | Transgenic animals | Hemoglobin | Sickle cell disease | P-selectin | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Guideline update for MASCC and ESMO in the prevention of chemotherapy-and radiotherapy-induced nausea and vomiting: Results of the Perugia consensus conference
by Roila, F and Herrstedt, J and Aapro, M and Gralla, R.J and Einhorn, L.H and Ballatori, E and Bria, E and Clark-Snow, R.A and Espersen, B.T and Feyer, P and Grunberg, S.M and Hesketh, P.J and Jordan, K and Kris, M.G and Maranzano, E and Molassiotis, A and Morrow, G and Olver, I and Rapoport, B.L and Rittenberg, C and Saito, M and Tonato, M and Warr, D and ESMO MASCC Guidelines Working Grp and ESMO/MASCC Guidelines Working Group
Annals of oncology, ISSN 0923-7534, 05/2010, Volume 21, Issue 5, pp. v232 - v243
Life Sciences & Biomedicine | Oncology | Science & Technology | Nausea - prevention & control | Vomiting - chemically induced | Nausea - chemically induced | Humans | Vomiting - drug therapy | Nausea - drug therapy | Vomiting - prevention & control | Practice Guidelines as Topic | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Pre-Exposure Prophylaxis for HIV Prevention : Safety Concerns
by Tetteh, Raymond A and Yankey, Barbara A and Nartey, Edmund T and Lartey, Margaret and Leufkens, Hubert G M and Dodoo, Alexander N O
Drug safety, ISSN 0114-5916, 04/2017, Volume 40, Issue 4, pp. 273 - 283
HIV Infections | Tenofovir | Animals | Humans | Anti-HIV Agents | Review | Journal Article | Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination | Pre-Exposure Prophylaxis | Medicine & Public Health | Drug Safety and Pharmacovigilance | Pharmacology/Toxicology | Pharmacology & Pharmacy | Public, Environmental & Occupational Health | Toxicology | Life Sciences & Biomedicine | Science & Technology | Anti-HIV Agents - administration & dosage | HIV Infections - prevention & control | Pre-Exposure Prophylaxis - methods | Tenofovir - adverse effects | Anti-HIV Agents - adverse effects | Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination - administration & dosage | Tenofovir - administration & dosage | Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination - adverse effects | Prevention | Clinical trials | Usage | Drug therapy | HIV infection | Intervention | Renal function | Toxicity | Liver | Prophylaxis | Viruses | Infections | Incidence | Mens health | Hepatitis | Acquired immune deficiency syndrome--AIDS | Vomiting | Human immunodeficiency virus--HIV | Risk assessment | Search engines | Bone density | Safety | Product safety | Drug dosages | Drug use | Monitoring | Emtricitabine | Enzymes | Medical research | Effectiveness | Health risks | Diarrhea | Exposure | Nausea | Pharmacology | Disease control | Disease prevention | Side effects | Disease transmission | Reviews | Bone mineral density | Kidney transplantation | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights